MD Anderson, AbbVie Connect to Advance Cancer Immunotherapy
Thursday, January 21, 2016 - 11:02
in Health & Medicine
The immunotherapy platform at The University of Texas MD Anderson Cancer Center and the global biopharmaceutical company AbbVie will join forces to find new ways to unleash the immune system's potential to fight cancer.